Genome-wide detection of allelic genetic variation to predict advanced-stage prostate cancer after radical prostatectomy using an exome SNP chip.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Jong Jin | - |
dc.contributor.author | Park, Seunghyun | - |
dc.contributor.author | Lee, Sang Eun | - |
dc.contributor.author | Hong, Sung Kyu | - |
dc.contributor.author | Lee, Sangchul | - |
dc.contributor.author | Jo, Jung Ki | - |
dc.contributor.author | Lee, Jung Keun | - |
dc.contributor.author | Ho, Jin-Nyoung | - |
dc.contributor.author | Yoon, Sungroh | - |
dc.contributor.author | Byun, Seok-Soo | - |
dc.date.accessioned | 2022-07-15T21:01:20Z | - |
dc.date.available | 2022-07-15T21:01:20Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2015-09 | - |
dc.identifier.issn | 1078-1439 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/156359 | - |
dc.description.abstract | Objectives: Genetic variations among patients with prostate cancer (PCa) who underwent radical prostatectomies were evaluated to predict advanced stage above T3 using an exome single nucleotide polymorphism (SNP) chip array. Materials and methods: We collected data of genetic SNP variants from 820 patients with PCa who underwent radical prostatectomy (RP) using a custom HumanExome BeadChip v1.0 (Illumina Inc.). We selected the SNPs that were most significantly associated with advanced-stage PCa (>= T3) among the 242,186 SNPs that were genotyped, and we compared the accuracies of the associations using a multivariate logistic model that incorporated clinical factors and clinicogenetic factors. Results: Among the total cohort, 360 patients (43.9%) had advanced pathologic stage (>= T3) after RP, of whom 262 (32.0%) had extracapsular extensions, 79 (9.6%) had seminal vesicle invasions, and 10 (1.3%) had bladder neck invasions. The exome array analysis indicated that 5 SNPs (rs6804162, rs8055236, rs56335308, rs6104, and rs12618769) were significant for predicting T3 stage after RP in patients with PCa. These genetic markers were significant factors after adjusting for other clinical parameters, and they increased the accuracy of a multivariate model for predicting advanced stage of PCa (83.9%-87.2%, P = 0.0001). Conclusions: Based on a genetic array, the selected SNPs were found to be independent predictors for advanced stage after RP, and the addition of individualized genetic information effectively enhanced the accuracy of predicting advanced-stage disease. These results should be validated in another independent cohort. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Elsevier | - |
dc.title | Genome-wide detection of allelic genetic variation to predict advanced-stage prostate cancer after radical prostatectomy using an exome SNP chip. | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jo, Jung Ki | - |
dc.identifier.doi | 10.1016/j.urolonc.2015.05.016 | - |
dc.identifier.scopusid | 2-s2.0-84940467304 | - |
dc.identifier.wosid | 000361037000008 | - |
dc.identifier.bibliographicCitation | Urologic Oncology: Seminars and Original Investigations, v.33, no.9, pp.385.e7 - 385.e13 | - |
dc.relation.isPartOf | Urologic Oncology: Seminars and Original Investigations | - |
dc.citation.title | Urologic Oncology: Seminars and Original Investigations | - |
dc.citation.volume | 33 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 385.e7 | - |
dc.citation.endPage | 385.e13 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | ABERRANT PROMOTER METHYLATION | - |
dc.subject.keywordPlus | CLINICAL STAGE | - |
dc.subject.keywordPlus | CLINICOPATHOLOGICAL FEATURES | - |
dc.subject.keywordPlus | EXTRACAPSULAR EXTENSION | - |
dc.subject.keywordPlus | PATHOLOGICAL STAGE | - |
dc.subject.keywordPlus | CADHERIN 13 | - |
dc.subject.keywordPlus | MEN | - |
dc.subject.keywordPlus | DISEQUILIBRIUM | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | VALIDATION | - |
dc.subject.keywordAuthor | Prostate cancel | - |
dc.subject.keywordAuthor | Exome array | - |
dc.subject.keywordAuthor | Stage | - |
dc.subject.keywordAuthor | Predictive value | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.